Norwegian Institute of Public Health, Oslo, Norway.
School of Law, Boston University, Boston, MA, USA; Chatham House Centre on Global Health Security, London, UK.
Lancet. 2016 Jan 16;387(10015):296-307. doi: 10.1016/S0140-6736(15)00470-5. Epub 2015 Nov 18.
Securing access to effective antimicrobials is one of the greatest challenges today. Until now, efforts to address this issue have been isolated and uncoordinated, with little focus on sustainable and international solutions. Global collective action is necessary to improve access to life-saving antimicrobials, conserving them, and ensuring continued innovation. Access, conservation, and innovation are beneficial when achieved independently, but much more effective and sustainable if implemented in concert within and across countries. WHO alone will not be able to drive these actions. It will require a multisector response (including the health, agriculture, and veterinary sectors), global coordination, and financing mechanisms with sufficient mandates, authority, resources, and power. Fortunately, securing access to effective antimicrobials has finally gained a place on the global political agenda, and we call on policy makers to develop, endorse, and finance new global institutional arrangements that can ensure robust implementation and bold collective action.
确保获得有效的抗菌药物是当今面临的最大挑战之一。迄今为止,为解决这一问题所做的努力孤立无援且缺乏协调,很少关注可持续和国际解决方案。需要采取全球集体行动来改善获得救命抗菌药物的机会,对其加以保护,并确保持续创新。在独立实现这些目标时,机会、保护和创新是有益的,但如果在国家内部和国家之间协调一致地实施,效果会更显著、可持续性也更强。仅凭世卫组织本身将无法推动这些行动。这将需要多部门的应对措施(包括卫生、农业和兽医部门)、全球协调以及具有充分授权、权威、资源和权力的供资机制。幸运的是,确保获得有效的抗菌药物最终已被提上全球政治议程,我们呼吁政策制定者制定、支持和资助新的全球体制安排,以确保有力的实施和大胆的集体行动。